The aim was to compare the effectiveness and safety of intravenous immunoglobulin (IVIg) or intravenous methylprednisolone (IVMP) versus IVIg plus IVMP (IPI) as initial therapy in anti‐N‐methyl‐d‐aspartate receptor (NMDAR) encephalitis. Click to show full abstract
The aim was to compare the effectiveness and safety of intravenous immunoglobulin (IVIg) or intravenous methylprednisolone (IVMP) versus IVIg plus IVMP (IPI) as initial therapy in anti‐N‐methyl‐d‐aspartate receptor (NMDAR) encephalitis.
               
Click one of the above tabs to view related content.